Edward Nash
Stock Analyst at Canaccord Genuity
(4.94)
# 166
Out of 4,978 analysts
374
Total ratings
54.1%
Success rate
31.1%
Average return
Main Sectors:
Stocks Rated by Edward Nash
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNTB Connect Biopharma Holdings | Reiterated: Buy | $7 → $6 | $1.24 | +383.87% | 5 | Sep 16, 2026 | |
| GPCR Structure Therapeutics | Reiterated: Buy | $111 | $35.50 | +212.68% | 4 | Sep 9, 2026 | |
| ACRS Aclaris Therapeutics | Initiated Coverage: Buy | $10 | $5.32 | +87.97% | 1 | Sep 1, 2026 | |
| NKTR Nektar Therapeutics | Reiterated: Buy | $153 | $67.38 | +127.07% | 3 | Aug 17, 2026 | |
| RANI Rani Therapeutics Holdings | Reiterated: Buy | $5 | $0.756 | +561.38% | 20 | Aug 17, 2026 | |
| TSX: CRDL Cardiol Therapeutics Inc. | Reiterated: Buy | $11.07 → $13.84 | $2.62 | +428.14% | 26 | Aug 17, 2026 | |
| CORT Corcept Therapeutics | Reiterated: Buy | $161 | $111.81 | +43.99% | 56 | Aug 13, 2026 | |
| PLRX Pliant Therapeutics | Reiterated: Hold | $3 | $1.07 | +180.37% | 16 | Aug 13, 2026 | |
| KNSA Kiniksa Pharmaceuticals International, | Reiterated: Buy | $98 | $77.62 | +26.26% | 5 | Aug 12, 2026 | |
| MDGL Madrigal Pharmaceuticals | Reiterated: Buy | $587 → $612 | $529.09 | +15.67% | 42 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 → $56 | $10.46 | +435.37% | 12 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $63.48 | +10.27% | 41 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $38.71 | +55.00% | 13 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $129 | $116.33 | +10.89% | 5 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $107 → $114 | $29.52 | +286.18% | 9 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 | $2.32 | +977.59% | 3 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $3.79 | +427.70% | 14 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $3.98 | n/a | 8 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $4.62 | n/a | 6 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 → $1 | $0.0001 | n/a | 2 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $7.78 | n/a | 2 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 | $2.04 | n/a | 1 | Jun 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $39 | $4.51 | n/a | 9 | May 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $176 | $19.76 | n/a | 15 | Feb 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 → $64 | $42.49 | n/a | 2 | Feb 26, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $126 → $117 | $64.73 | n/a | 14 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $54 → $71 | $12.88 | n/a | 11 | Jan 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $156 | $54.31 | n/a | 1 | Sep 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $132 | $984.69 | n/a | 1 | Sep 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $22 → $4 | $17.30 | n/a | 3 | Jun 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $17.63 | n/a | 1 | Jun 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $23 | $5.37 | n/a | 2 | May 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $0.0001 | n/a | 1 | Sep 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 → $2 | $0.0001 | n/a | 2 | May 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $6 | $3.93 | n/a | 8 | May 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | $10.12 | n/a | 3 | Mar 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 → $11 | $4.17 | n/a | 3 | Sep 4, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $0.1476 | n/a | 1 | Jun 17, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $16.22 | n/a | 2 | May 3, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $27.54 | n/a | 1 | Jan 28, 2013 |
Connect Biopharma Holdings
Sep 16, 2026
Reiterated: Buy
Price Target: $7 → $6
Current: $1.24
Upside: +383.87%
Structure Therapeutics
Sep 9, 2026
Reiterated: Buy
Price Target: $111
Current: $35.50
Upside: +212.68%
Aclaris Therapeutics
Sep 1, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $5.32
Upside: +87.97%
Nektar Therapeutics
Aug 17, 2026
Reiterated: Buy
Price Target: $153
Current: $67.38
Upside: +127.07%
Rani Therapeutics Holdings
Aug 17, 2026
Reiterated: Buy
Price Target: $5
Current: $0.756
Upside: +561.38%
Cardiol Therapeutics Inc.
Aug 17, 2026
Reiterated: Buy
Price Target: $11.07 → $13.84
Current: $2.62
Upside: +428.14%
Corcept Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $161
Current: $111.81
Upside: +43.99%
Pliant Therapeutics
Aug 13, 2026
Reiterated: Hold
Price Target: $3
Current: $1.07
Upside: +180.37%
Kiniksa Pharmaceuticals International,
Aug 12, 2026
Reiterated: Buy
Price Target: $98
Current: $77.62
Upside: +26.26%
Madrigal Pharmaceuticals
Aug 11, 2026
Reiterated: Buy
Price Target: $587 → $612
Current: $529.09
Upside: +15.67%
Aug 11, 2026
Reiterated: Buy
Price Target: $49 → $56
Current: $10.46
Upside: +435.37%
Aug 11, 2026
Reiterated: Buy
Price Target: $70
Current: $63.48
Upside: +10.27%
Aug 6, 2026
Reiterated: Buy
Price Target: $60
Current: $38.71
Upside: +55.00%
Aug 6, 2026
Reiterated: Buy
Price Target: $129
Current: $116.33
Upside: +10.89%
Jul 30, 2026
Reiterated: Buy
Price Target: $107 → $114
Current: $29.52
Upside: +286.18%
May 14, 2026
Rated: Buy
Price Target: $25
Current: $2.32
Upside: +977.59%
Apr 2, 2026
Reiterated: Buy
Price Target: $20
Current: $3.79
Upside: +427.70%
Oct 2, 2024
Reiterated: Buy
Price Target: $9
Current: $3.98
Upside: n/a
May 17, 2023
Reiterated: Hold
Price Target: $2
Current: $4.62
Upside: n/a
Jul 29, 2022
Downgraded: Hold
Price Target: $12 → $1
Current: $0.0001
Upside: n/a
May 18, 2021
Reiterated: Buy
Price Target: $25
Current: $7.78
Upside: n/a
Jun 5, 2019
Downgraded: Hold
Price Target: $5
Current: $2.04
Upside: n/a
May 20, 2019
Reiterated: Buy
Price Target: $60 → $39
Current: $4.51
Upside: n/a
Feb 27, 2019
Reiterated: Buy
Price Target: $176
Current: $19.76
Upside: n/a
Feb 26, 2019
Reiterated: Buy
Price Target: $48 → $64
Current: $42.49
Upside: n/a
Feb 25, 2019
Reiterated: Buy
Price Target: $126 → $117
Current: $64.73
Upside: n/a
Jan 23, 2019
Reiterated: Buy
Price Target: $54 → $71
Current: $12.88
Upside: n/a
Sep 24, 2018
Reiterated: Buy
Price Target: $156
Current: $54.31
Upside: n/a
Sep 17, 2018
Reiterated: Buy
Price Target: $132
Current: $984.69
Upside: n/a
Jun 27, 2018
Downgraded: Hold
Price Target: $22 → $4
Current: $17.30
Upside: n/a
Jun 25, 2018
Initiated Coverage: Buy
Price Target: $26
Current: $17.63
Upside: n/a
May 16, 2018
Reiterated: Buy
Price Target: $26 → $23
Current: $5.37
Upside: n/a
Sep 18, 2017
Reiterated: Buy
Price Target: $24
Current: $0.0001
Upside: n/a
May 16, 2017
Reiterated: Hold
Price Target: $1 → $2
Current: $0.0001
Upside: n/a
May 5, 2017
Reiterated: Hold
Price Target: $3 → $6
Current: $3.93
Upside: n/a
Mar 7, 2017
Reiterated: Hold
Price Target: $9
Current: $10.12
Upside: n/a
Sep 4, 2014
Downgraded: Hold
Price Target: $14 → $11
Current: $4.17
Upside: n/a
Jun 17, 2013
Initiated Coverage: Buy
Price Target: n/a
Current: $0.1476
Upside: n/a
May 3, 2013
Downgraded: Sell
Price Target: n/a
Current: $16.22
Upside: n/a
Jan 28, 2013
Initiated Coverage: Buy
Price Target: n/a
Current: $27.54
Upside: n/a